Status | Study |
Recruiting |
Study Name: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Condition: Malignant Peripheral Nerve Sheath Tumors Date: 2017-04-13 |
Active, not recruiting |
Study Name: Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 Condition: Neurofibromatosis 1 Cutaneous Neurofibroma Date: 2017-03-08 Interventions: Drug: Diclofenac Sodium Follow |
Recruiting |
Study Name: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Condition: Malignant Peripheral Nerve Sheath Tumour (MPNST) Date: 2016-02-04 Interventions: Drug: Pembrolizumab Other Name: Keytruda |
Recruiting |
Study Name: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Condition: Sarcoma Malignant Peripheral Nerve Sheath Tumors Date: 2015-10-21 Interventions: Drug: PLX3397 PLX3397 is a sel |
Recruiting |
Study Name: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs) Condition: Neurofibromatosis 1 Plexiform Neurofibromas Date: 2015-09-05 |
Recruiting |
Study Name: Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain Condition: Neurofibromatosis Type 1 Plexiform Neurofibromas Date: 2015-06-12 Interventions: Other: Acceptance and Commitment Therapy (ACT) Acceptance and Commitment Therapy (ACT), a newer generati |
Recruiting |
Study Name: Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery Condition: Neurofibromatosis Type 1 Plexiform Neurofibroma Date: 2015-04-02 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach. Condition: Cutaneous Neurofibromas Neurofibromatosis Type 1 Date: 2015-01-21 Interventions: Procedure: Skin Biopsy The procedure to sample the cutaneo |
Recruiting |
Study Name: Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas Condition: Plexiform Neurofibromas Date: 2014-06-25 Interventions: Drug: Imatinib Mesylate oral administration Other Na |
Active, not recruiting |
Study Name: Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +) Condition: NF1 Neurofibromatosis Plexiform Neur Date: 2014-03-14 Interventions: Drug: Cabozantinib Open label Phase II clinical trials. All subjects will start cabozantinib at 40 mg. S |